Health & Fitness
Thu, February 3, 2011Wed, February 2, 2011Tue, February 1, 2011Mon, January 31, 2011Sun, January 30, 2011Fri, January 28, 2011Thu, January 27, 2011Wed, January 26, 2011Tue, January 25, 2011Mon, January 24, 2011Sun, January 23, 2011Sat, January 22, 2011Fri, January 21, 2011Thu, January 20, 2011Wed, January 19, 2011Tue, January 18, 2011Mon, January 17, 2011Fri, January 14, 2011Thu, January 13, 2011Wed, January 12, 2011Tue, January 11, 2011Mon, January 10, 2011Sun, January 9, 2011Fri, January 7, 2011Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2010
Published in Health and Fitness on Tuesday, January 25th 2011 at 5:10 GMT by Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2010 -- VENLO, Netherlands, Jan. 25, 2011 /PRNewswire/ --
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2010
Financial Results Call Set for February 1
VENLO, Netherlands, Jan. 25,2011 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: [ QGEN ]) today announced the Webcast of its fourth quarter and year-end 2010 financial results call. The Webcast will take place at 9:30 a.m. EST on Tuesday, February 1, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
What: | Webcast of QIAGEN's fourth quarter and year-end 2010 financial results call | |
When: | 9:30 a.m. EST on February 1 | |
Where: | The Webcast is accessible at [ www.qiagen.com/goto/ConferenceCall ] | |
How: | Log on to the Web at the address above | |
The corresponding presentation slides will be available for download in the investor relations section of QIAGEN's Web site at [ www.qiagen.com/goto/ConferenceCall ].
Contact: Andreas Marathovouniotis, Russo Partners, (212) 845-4235
QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics.
QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at [ http://www.qiagen.com/ ].
(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from [ http://www.real.com/products/player/index.html ], or The Windows Media Player, downloadable free from [ www.microsoft.com ] and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to [ prnwebcast@multivu.com ].)
SOURCE QIAGEN N.V.
[ Back to top ]RELATED LINKS
[ http://www.qiagen.com ]
